Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2008 1
2017 1
2020 1
2021 3
2022 3
2023 5
2024 3
2025 5
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Manual Lymph Drainage With Progressive Arm Exercises for Axillary Web Syndrome After Breast Cancer Surgery: A Randomized Controlled Trial.
Torres-Lacomba M, Prieto-Gómez V, Arranz-Martín B, Ferrandez JC, Yuste-Sánchez MJ, Navarro-Brazález B, Romay-Barrero H. Torres-Lacomba M, et al. Phys Ther. 2022 Mar 1;102(3):pzab314. doi: 10.1093/ptj/pzab314. Phys Ther. 2022. PMID: 35079831 Free article. Clinical Trial.
OBJECTIVE: This study aimed to determine the effectiveness of a physical therapist-designed program tailored to axillary web syndrome (AWS) in women after breast cancer surgery. METHODS: A prospective, single-center, assessor-blinded, randomized controlled trial was …
OBJECTIVE: This study aimed to determine the effectiveness of a physical therapist-designed program tailored to axillary web syndrome (AWS) …
Identification and validation of a small molecule targeting ROR1 for the treatment of triple negative breast cancer.
Gupta SRR, Ta TM, Khan M, Singh A, Singh IK, Peethambaran B. Gupta SRR, et al. Front Cell Dev Biol. 2023 Sep 13;11:1243763. doi: 10.3389/fcell.2023.1243763. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37779899 Free PMC article.
Introduction: Breast cancer is the most common cancer in women, with roughly 10-15% of new cases classified as triple-negative breast cancer (TNBC). ...Compound 4 did not kill non-malignant epithelial breast cells MCF-10A (IC(50) > 27 …
Introduction: Breast cancer is the most common cancer in women, with roughly 10-15% of new cases classified as triple-n …
In-silico identification of potential inhibitors targeting the DNA binding domain of estrogen receptor alpha for the treatment of hormone therapy-resistant breast cancer.
Bouricha EM, Hakmi M, Akachar J, Zouaidia F, Ibrahimi A. Bouricha EM, et al. J Biomol Struct Dyn. 2022 Jul;40(11):5203-5210. doi: 10.1080/07391102.2020.1869094. Epub 2021 Jan 6. J Biomol Struct Dyn. 2022. PMID: 33402049
Estrogen receptor alpha (ERalpha) plays a critical role in breast cancer (BC) development. The standard therapeutic strategies for ERalpha- positive (ERalpha+) BC consist of impairing ERalpha signalling pathway by either estrogen competitors blocking its interaction …
Estrogen receptor alpha (ERalpha) plays a critical role in breast cancer (BC) development. The standard therapeutic strategies …
Surgical treatment for skeletal breast cancer metastases: a population-based study of 641 patients.
Wedin R, Bauer HC, Rutqvist LE. Wedin R, et al. Cancer. 2001 Jul 15;92(2):257-62. doi: 10.1002/1097-0142(20010715)92:2<257::aid-cncr1317>3.0.co;2-r. Cancer. 2001. PMID: 11466677
BACKGROUND: The objective of this article was to assess the occurrence of symptomatic bone metastases in a defined population of patients with breast carcinoma and to characterize the clinical outcome with reference to surgical treatment for pathologic fracture or n …
BACKGROUND: The objective of this article was to assess the occurrence of symptomatic bone metastases in a defined population of patients wi …
3-deazaadenosine: A promising novel p38gamma antagonist with potential as a breast cancer therapeutic agent.
Natarajan P, Manne M, Koduru SK, Bokkasam TS. Natarajan P, et al. Cancer Treat Res Commun. 2023;36:100744. doi: 10.1016/j.ctarc.2023.100744. Epub 2023 Jul 16. Cancer Treat Res Commun. 2023. PMID: 37481995 Free article.
P38gamma has a significant contribution to the progression of breast carcinoma due to its multifaceted functions. Targeting p38gamma for defining potent antagonists against p38gamma can turn out to be an attractive and novel means of breast cancer therapeutic …
P38gamma has a significant contribution to the progression of breast carcinoma due to its multifaceted functions. Targeting p38gamma …
Considering wider myofascial involvement as a possible contributor to upper extremity dysfunction following treatment for primary breast cancer.
Fourie WJ. Fourie WJ. J Bodyw Mov Ther. 2008 Oct;12(4):349-55. doi: 10.1016/j.jbmt.2008.04.043. Epub 2008 Jun 27. J Bodyw Mov Ther. 2008. PMID: 19083693
BACKGROUND: Breast cancer is the most common malignancy in women. Although scarring is recognized as contributing to limited shoulder movements, compromised tissue gliding in a wider range of fascial and connective tissue structures is under-recognized. ...DI …
BACKGROUND: Breast cancer is the most common malignancy in women. Although scarring is recognized as contributing to limited s …
Key target genes related to anti-breast cancer activity of ATRA: A network pharmacology, molecular docking and experimental investigation.
Manoochehri H, Farrokhnia M, Sheykhhasan M, Mahaki H, Tanzadehpanah H. Manoochehri H, et al. Heliyon. 2024 Jul 9;10(14):e34300. doi: 10.1016/j.heliyon.2024.e34300. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39108872 Free PMC article.
CCND1, ESR1, and MDM2 were associated with poor treatment response and were downregulated after treatment of the breast cancer cell line with ATRA. CCND1 and ESR1 exhibited differential expression across breast cancer stages. Therefore, s …
CCND1, ESR1, and MDM2 were associated with poor treatment response and were downregulated after treatment of the breast …
Discovery of potent CSK inhibitors through integrated virtual screening and molecular dynamic simulation.
Chen R, Wang Y, Shen Z, Ye C, Guo Y, Lu Y, Ding J, Dong X, Xu D, Zheng X. Chen R, et al. Arch Pharm (Weinheim). 2024 Sep;357(9):e2400066. doi: 10.1002/ardp.202400066. Epub 2024 May 29. Arch Pharm (Weinheim). 2024. PMID: 38809025
Oncogenic overexpression or activation of C-terminal Src kinase (CSK) has been shown to play an important role in triple-negative breast cancer (TNBC) progression, including tumor initiation, growth, metastasis, drug resistance. ...Treatment with molecule 2 a …
Oncogenic overexpression or activation of C-terminal Src kinase (CSK) has been shown to play an important role in triple-negative breast …
Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.
Yousif FA, Alzain AA, Alraih AM, Ibraheem W. Yousif FA, et al. PLoS One. 2023 Sep 8;18(9):e0291256. doi: 10.1371/journal.pone.0291256. eCollection 2023. PLoS One. 2023. PMID: 37682937 Free PMC article.
Breast cancer is a leading cause of cancer-related morbidity and mortality worldwide, with the highest incidence among women. ...To address this, the first-line treatment for ER+ breast cancer focuses on inhibiting estrogen production by …
Breast cancer is a leading cause of cancer-related morbidity and mortality worldwide, with the highest incidence among …
An Exploratory Randomized Trial of Physical Therapy for the Treatment of Chemotherapy-Induced Peripheral Neuropathy.
Andersen Hammond E, Pitz M, Steinfeld K, Lambert P, Shay B. Andersen Hammond E, et al. Neurorehabil Neural Repair. 2020 Mar;34(3):235-246. doi: 10.1177/1545968319899918. Epub 2020 Jan 24. Neurorehabil Neural Repair. 2020. PMID: 31976819 Clinical Trial.
Single-blind, randomized controlled exploratory study compared standard care to a physical therapy home program (4 visits) throughout adjuvant taxane chemotherapy for stage I-III patients with breast cancer (n = 48). Patient questionnaires and quantitative sensory t …
Single-blind, randomized controlled exploratory study compared standard care to a physical therapy home program (4 visits) throughout adjuva …
21 results